Amanote Research
Register
Sign In
Abstract P6-20-02: Activity of Larotrectinib, a Highly Selective Inhibitor of Tropomyosin Receptor Kinase, in TRK Fusion Breast Cancers
doi 10.1158/1538-7445.sabcs18-p6-20-02
Full Text
Open PDF
Abstract
Available in
full text
Date
February 15, 2019
Authors
F Meric-Bernstam
N Shukla
N Peled
Y Landman
A Onitilo
S Montez
NC Ku
DM Hyman
A Drilon
DS Hong
Publisher
American Association for Cancer Research
